Procter & Gamble Health Limited (NSE:PGHL)
India · Delayed Price · Currency is INR 5,434.50
-25.50 (-0.47%)
Sep 17, 2026, 3:29 PM IST
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 90.63 billion as of September 17, 2026. Its market cap has decreased by -13.96% in one year.
Market Cap
90.63B
Enterprise Value
88.87B
Revenue
14.33B
Ranking
n/a
PE Ratio
25.39
Stock Price
5,434.50
ChartMarket Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 90.63B, an increase of 829.91%. That is a compound annual growth rate of 8.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 90.22B | -4.67% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alivus Life Sciences | 168.23B |
| Cohance Lifesciences | 165.63B |
| Alembic Pharmaceuticals | 162.22B |
| NATCO Pharma | 145.67B |
| Sudeep Pharma | 125.06B |
| Akums Drugs and Pharmaceuticals | 118.19B |
| Strides Pharma Science | 109.12B |
| Aarti Pharmalabs | 73.70B |